Sarcopenia study in older adults with type 2 diabetes
Part of Brain & nervous system clinical trials.
This study looks at muscle loss (sarcopenia) in people 60 and older who have had type 2 diabetes for at least 5 years. It aims to understand how diabetes might affect muscle health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older
- You have been diagnosed with type 2 diabetes for at least 5 years
- You are able to give your permission to join the study
- You do not have chronic kidney or liver disease
- You do not have severe memory or thinking problems
- You do not have a muscle or nerve disease that affects walking
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at sarcopenia, which is age-related loss of muscle, in people with certain types of heart failure or in people with stable type 2 diabetes but no symptoms. The goal is to better understand muscle changes and what might help people stay stronger.
This trial tests whether a specific strength-training program (called progressive resistance training) can help older adults with both type 2 diabetes and sarcopenia (muscle loss) improve muscle strength and overall function.
This study is looking at how certain sugar-related proteins (called AGEs) might be linked to muscle loss in people with obesity and type 2 diabetes. It aims to understand why muscle wasting happens in this condition.
This study tests whether a special exercise program can help middle-aged and older adults who have both type 2 diabetes and muscle loss. It aims to improve muscle strength, balance, and overall health.
This study tests a short, combined exercise program (mixing cardio and strength training) for people 60+ with type 2 diabetes who have signs of muscle loss. The goal is to see if this exercise approach can improve strength, physical function, and overall health.
This study examines how nerve damage from diabetes (diabetic neuropathy) relates to muscle loss in people with type 2 diabetes. It aims to help understand and possibly prevent muscle weakness.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.